Lewis SJ - Search Results

1

McGee EU, Samuel E, Boronea B, Dillard N, Milby MN, Lewis SJ. McGee EU, et al. Among authors: lewis sj. Pharmacy (Basel). 2019 Jul 19;7(3):97. doi: 10.3390/pharmacy7030097. Pharmacy (Basel). 2019. PMID: 31330937 Free PMC article. Review.

2

Comparison of antimicrobial dosing recommendations in patients receiving intermittent hemodialysis among drug information resources.

Lewis SJ, Bodenhorn D, Na EY, Jang SM. Lewis SJ, et al. J Clin Pharm Ther. 2022 May;47(5):628-635. doi: 10.1111/jcpt.13583. Epub 2021 Dec 5. J Clin Pharm Ther. 2022. PMID: 34866202

3

Novel therapeutic agents for the treatment of diabetic kidney disease.

Hartman RE, Rao PSS, Churchwell MD, Lewis SJ. Hartman RE, et al. Among authors: lewis sj. Expert Opin Investig Drugs. 2020 Nov;29(11):1277-1293. doi: 10.1080/13543784.2020.1811231. Epub 2020 Sep 14. Expert Opin Investig Drugs. 2020. PMID: 32799584 Review.

4

Author response: "An optimal extended-infusion dosing of cefepime and ceftazidime in critically ill patients with continuous renal replacement therapy".

Sember AM, LoFaso ME, Lewis SJ. Sember AM, et al. Among authors: lewis sj. J Crit Care. 2022 Aug;70:154059. doi: 10.1016/j.jcrc.2022.154059. Epub 2022 May 11. J Crit Care. 2022. PMID: 35568021 No abstract available.

5

An optimal extended-infusion dosing of cefepime and ceftazidime in critically ill patients with continuous renal replacement therapy.

Sember AM, LoFaso ME, Lewis SJ. Sember AM, et al. Among authors: lewis sj. J Crit Care. 2022 Jun;69:154011. doi: 10.1016/j.jcrc.2022.154011. Epub 2022 Feb 21. J Crit Care. 2022. PMID: 35202996

6

Erratum to "Impact of pharmacist intervention to deprescribe inappropriate aspirin therapy in an outpatient anticoagulation clinic at a community hospital" [Am. Heart J. Plus: Cardiol. Res. Pract. volume 17, May 2022, 100165].

Domaleczny BJ, Lewis SJ, Richardson JL, Eid HR. Domaleczny BJ, et al. Among authors: lewis sj. Am Heart J Plus. 2023 May 1;29:100297. doi: 10.1016/j.ahjo.2023.100297. eCollection 2023 May. Am Heart J Plus. 2023. PMID: 38510676 Free PMC article.

7

Antibiotic dosing recommendations in critically ill patients receiving new innovative kidney replacement therapy.

Lewis SJ, Mueller BA. Lewis SJ, et al. BMC Nephrol. 2024 Feb 27;25(1):73. doi: 10.1186/s12882-024-03469-2. BMC Nephrol. 2024. PMID: 38413858 Free PMC article.

8

Telavancin pharmacokinetics in patients with chronic kidney disease receiving haemodialysis.

Gharibian KN, Lewis SJ, Heung M, Segal JH, Salama NN, Mueller BA. Gharibian KN, et al. Among authors: lewis sj. J Antimicrob Chemother. 2021 Dec 24;77(1):174-180. doi: 10.1093/jac/dkab370. J Antimicrob Chemother. 2021. PMID: 34613416

9

Development of a vancomycin dosing approach for critically ill patients receiving hybrid hemodialysis using Monte Carlo simulation.

Lewis SJ, Mueller BA. Lewis SJ, et al. SAGE Open Med. 2018 May 11;6:2050312118773257. doi: 10.1177/2050312118773257. eCollection 2018. SAGE Open Med. 2018. PMID: 29780587 Free PMC article.

10

Vancomycin and daptomycin dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation.

Lewis SJ, Jang SM, Mueller BA. Lewis SJ, et al. BMC Nephrol. 2023 Sep 14;24(1):270. doi: 10.1186/s12882-023-03314-y. BMC Nephrol. 2023. PMID: 37710245 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,078 results

Search Page